Provided by Tiger Trade Technology Pte. Ltd.

Agilent

154.77
+1.340.87%
Post-market: 155.400.6300+0.41%19:55 EDT
Volume:2.43M
Turnover:374.89M
Market Cap:43.81B
PE:31.08
High:155.16
Open:153.90
Low:152.27
Close:153.43
52wk High:160.51
52wk Low:108.35
Shares:283.05M
Float Shares:281.64M
Volume Ratio:0.85
T/O Rate:0.86%
Dividend:1.01
Dividend Rate:0.65%
EPS(TTM):4.98
EPS(LYR):4.59
ROE:21.33%
ROA:8.61%
PB:6.15
PE(LYR):33.73

Loading ...

Revvity Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 25

Billionaire Investor Dumps Thermo Fisher, Cuts Danaher As He Pares Life Sciences Tools Bets

Benzinga Earnings
·
Jul 25

FangDD Received Nasdaq Notification Regarding Minimum Bid Price Requirement

GlobeNewswire
·
Jul 24

Agilent Technologies Inc. Stock Underperforms Thursday When Compared to Competitors Despite Daily Gains

Dow Jones
·
Jul 24

Agilent Declares Q2 2026 Distribution of R$ 0.44 Per Unit, Payable July 28

Reuters
·
Jul 24

Real Messenger Announces Receipt of Nasdaq Notification Letter Regarding Minimum Price Deficiency

GlobeNewswire
·
Jul 23

Agilent Receives EU Certification for Keytruda Companion Diagnostic in Gynecologic Cancers

MT Newswires Live
·
Jul 23

Agilent receives EU approval for PD-L1 IHC 22C3 pharmDx

TIPRANKS
·
Jul 23

Agilent Wins EU Approval for PD-L1 IHC 22C3 Test in Ovarian Cancer Patients

Reuters
·
Jul 23

Agilent Receives EU Approval for Pd-l1 Ihc 22C3 Pharmdx in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Carcinoma

THOMSON REUTERS
·
Jul 23

Agilent Technologies - Approval Expands Pd-l1 Testing to Support Keytruda Treatment Decisions

THOMSON REUTERS
·
Jul 23

Bernstein Sticks to Its Buy Rating for Agilent (A)

TIPRANKS
·
Jul 23

Agilent BDR Program Executes 5-for-1 Stock Split on Ratio Adjustment

Reuters
·
Jul 22

Agilent Technologies (A) Wins FDA Approval, Where Does Fair Value Sit Now?

Simply Wall St.
·
Jul 21

Mettler-toledo International Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 21

DT Cloud Star Acquisition Corporation Receives Nasdaq Delist Determinization Letter

GlobeNewswire
·
Jul 21

Revvity Inc. Stock Slides 3.4%, Underperforms Peers

Dow Jones
·
Jul 21

FDA-Approved PD-L1 Test for GI Cancers Could Be A Game Changer For Agilent Technologies (A)

Simply Wall St.
·
Jul 19

Mettler-toledo International Inc. Stock Underperforms Friday When Compared to Competitors

Dow Jones
·
Jul 18

Helport AI Limited Receives Standard Nasdaq Notification Regarding Minimum Bid Price Requirement

GlobeNewswire
·
Jul 18